RxSight Q3 Earnings Preview Gives Revenue Estimate
RxSight is scheduled to report Q3 results on November 03 after the market closes. Revenue is estimated at 27.19 million USD, with EPS anticipated at (0.31) USD.
Related stories
Bambusa Therapeutics Prices Upsized IPO
M impact | EQUITY | Oct 30, 2026, 12:16 AM UTC
Nikkei Falls 1.3% as Electronics and Metals Stocks Lead Declines
Japanese stocks are lower ahead of the Bank of Japan’s rate decision and after Alphabet shares sold off overnight. Advantest is down 5.3% and JX Advanced Metals is 4.0% lower.
M impact | EQUITY | Oct 30, 2026, 12:15 AM UTC
Toggle Holdings Opens Below Its IPO Price
L impact | EQUITY | Oct 30, 2026, 12:14 AM UTC
ICE Publishes Q3 2026 Earnings Call Transcript
M impact | EQUITY | Oct 30, 2026, 12:14 AM UTC
Spectur Reports Q1 FY27 Revenue of A$1.47 Million
Q1 FY27 revenue included A$1.22 million in recurring revenue.
M impact | EQUITY | Oct 30, 2026, 12:12 AM UTC
StrategX Elements Raises $911,110.95 in Private Placement
StrategX Elements raised $911,110.95 in an oversubscribed private placement.
M impact | EQUITY | Oct 30, 2026, 12:12 AM UTC